# Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread

> **NCT03569436** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 262 (actual)

## Conditions studied

- Cancer of Head and Neck
- Cancer of the Head
- Cancer of the Neck

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03569436
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2020-06-26
- **Final completion:** 2020-06-26
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2022-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569436, "Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03569436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*